Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Protective Effect of N-Acetylcysteine on Kidney As a Remote Organ After Skeletal Muscle Ischemia-Reperfusionspi; [Efeito Protetor Da N-Acetilcisteina No Rim Como Um Orgao Remoto Musculo Esqueletico Apos Isquemia-Reperfusao] Publisher Pubmed



Takhtfooladi MA1 ; Jahanshahi A1 ; Jahanshahi G2 ; Sotoudeh A3 ; Takhtfooladi HA4 ; Khansari M5
Authors

Source: Acta Cirurgica Brasileira Published:2012


Abstract

PURPOSE: To investigate whether N-acetylcysteine has a protective effect against renal injury as a remote organ after skeletal muscle ischemia-reperfusion in rats. METHODS: Twenty Wistar male rats were divided randomly into two experimental groups: group ischemia-reperfusion (group I) and group ischemia-reperfusion + N-acetylcysteine (group II). After ketamine and xylazine anesthesia, femoral artery was exposed. All animals were undergone 2h of ischemia by occlusion femoral artery and 24h of reperfusion. Rats that were treated with N-acetylcysteine given IV at a dose of 150 mg/kg-1, immediately before reperfusion. After 24h of reperfusion, the blood samples were collected and submitted for evaluation of plasmatic urea, creatinine values and then rats were euthanized and left kidney harvested for histopathological analysis under light microscopy. RESULTS: The urea (35±7.84 mg.dL-1), creatinine (1.46±0.47 mg.dL-1) values were significantly lower in group II (P=0.000). Renal histopathologic study in group I showed extensive distal and proximal tubular cells necrosis and sloughing of epithelial cells into the tubular lumen, cast formation in tubule and glomerul, glomerul fibrosis and hemorrhage. Histopathologically, there was a significant difference (p=0.037) between two groups. CONCLUSION: The N-acetylcysteine was able to decrease renal injury induced by skeletal muscle ischemia reperfusion in rats.
Other Related Docs
15. Vitamin E in the Prevention of Vancomycin-Induced Nephrotoxicity, Research in Pharmaceutical Sciences (2020)